TrialVirology journal2023

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.

Masoud Solaymani-Dodaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.